It may seem incongruous to the average person why Philip Morris (PM) would back legislation to restrict its business, yet that is what PM seems to be is doing by supporting S. 625, the "Family Smoking Prevention and Tobacco Control Act," the bill that would give the U.S. Food and Drug Administration (FDA) authority over tobacco products. After all, PM has a corporate mandate to increase profits for its shareholders, so PM would not support this legislation if it wasn't going to benefit its bottom line, and it is practically an axiom in public health that whatever benefits PM's bottom line is going to be bad for public health. That's what makes this bill especially troubling to people who study tobacco industry documents; it is clear that PM had a hand in crafting it. That alone sounds like a lot, but PM's efforts to enact it are clearly delivering the company a hefty side-benefit of causing dissent within the tobacco control community over its passage.